옵션 체인은 다양한 행사가격과 만기일에 대한 Sibanye Stillwater의 주식 옵션 주요 데이터를 보여줍니다. 트레이더들은 이 정보를 사용하여 잠재적 거래를 분석하고 Sibanye Stillwater에 대한 시장 심리를 평가합니다..

Sibanye Stillwater (NYSE:SBSW) 주식, 옵션 체인

Sibanye Stillwater

Sibanye Stillwater Ltd is a South African mining and metals processing group with a diverse portfolio of operations, projects, and investments across five continents. The Group is also one of the foremost recyclers of PGM autocatalysts and has interests in mine tailings retreatment operations. It is a producer of platinum, palladium, and rhodium and is a top-tier gold producer. It also produces and refines iridium and ruthenium, nickel, chrome, copper, and cobalt. Its products are Gold, Nickel, Zinc, Chrome, PGMs, and other.

Microstrategy, Marathon Digital Holdings, Coinbase, Cleanspark, And Tesla: 5 Stocks On Investors' Radars Today Amid Bitcoin Buzz

Equities

Mid Cap

News

Movers

Trading Ideas

ALGM

BILI

MARA

SBSW

TGTX

지난주 급등한 중형주 8종목 (3월 3일~7일) TG 테라퓨틱스 알레그로 마이크로시스템즈 시바니 스틸워터 하모니 골드 마이닝 빌리빌리 지커 존 윌리 앤 손 마라 홀딩스

빌리빌리·마라홀딩스·지커 등 지난주 급등한 중형주 8종목 (3월 3일~7일)

Sibanye Stillwater Ltd

Citigroup analyst Ariel Rosa upgrades Knight-Swift (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KNX#NYSE">KNX</a>) from Sell to Neutral and announces $53 price target.

Upgrades

Price Target

Analyst Ratings

Citigroup Upgrades Knight-Swift to Neutral, Announces $53 Price Target

MLYS

Trading Halt: Halt status updated at 7:25:00 AM ET: Quotation Resumption: News and Resumption Times

Citigroup analyst Jeff Chung upgrades XPeng (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/XPEV#NYSE">XPEV</a>) from Neutral to Buy and raises the price target from $13.7 to $29.

XPEV

Citigroup Upgrades XPeng to Buy, Raises Price Target to $29

WIIM

Mineralys Therapeutics shares are trading higher after the company reported topline data from its pivotal LAUNCH-HTN Phase 3 and ADVANCE-HTN Phase 2 trials of Lorundrostat for hypertension. Both trials met the primary endpoint.

HC Wainwright &amp; Co. analyst Arthur He maintains Solid Biosciences (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/SLDB#NASDAQ">SLDB</a>) with a Buy and raises the price target from $16 to $20.

SLDB

HC Wainwright & Co. Maintains Buy on Solid Biosciences, Raises Price Target to $20

Earnings

Cheer Holding Reported FY24 Revenue Of $147.2M Vs $152.3M YoY, EPS Of $2.51 Vs $3.53 YoY

TRVI

Trevi Therapeutics shares are trading higher after the company reported topline results from its Phase 2a RIVER trial of Haduvio for RCC, which met the primary endpoint.

Citigroup analyst Keith Horowitz upgrades KeyCorp (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/KEY#NYSE">KEY</a>) from Neutral to Buy and announces $20 price target.

Citigroup Upgrades KeyCorp to Buy, Announces $20 Price Target

RDFN

Redfin shares are trading higher after Rocket Companies announced it will acquire the company in an all-stock transaction valued at $12.50 per share.

Rocket Companies shares are trading lower after the company announced it will acquire Redfin in an all-stock transaction valued at $12.50 per share.

Novo Nordisk shares are trading lower after the company reported Phase 3 results for CagriSema, showing 15.7% weight loss over 68 weeks.

HC Wainwright &amp; Co. analyst Swayampakula Ramakanth reiterates Elevation Oncology (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/ELEV#NASDAQ">ELEV</a>) with a Buy and maintains $6 price target.

Reiteration

ELEV

HC Wainwright & Co. Reiterates Buy on Elevation Oncology, Maintains $6 Price Target

DASH

DoorDash shares are trading higher amid the company joining the S&P 500.

Barclays analyst Julian Mitchell downgrades Emerson Electric (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) from Equal-Weight to Underweight and lowers the price target from $135 to $110.

Downgrades

Barclays Downgrades Emerson Electric to Underweight, Lowers Price Target to $110

ABNB

Airbnb shares are trading higher after Jefferies upgraded the stock from Hold to Buy and raised its price target from $165 to $185.

HC Wainwright &amp; Co. analyst Douglas Tsao reiterates Protagonist Therapeutics (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/PTGX#NASDAQ">PTGX</a>) with a Buy and maintains $54 price target.

PTGX

HC Wainwright & Co. Reiterates Buy on Protagonist Therapeutics, Maintains $54 Price Target

HC Wainwright &amp; Co. analyst Amit Dayal reiterates Gevo (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/GEVO#NASDAQ">GEVO</a>) with a Buy and maintains $14 price target.

GEVO

HC Wainwright & Co. Reiterates Buy on Gevo, Maintains $14 Price Target

This one business day extension is to accommodate the settlement and tendering of shares of AspenTech common stock that may be sold due to the S&amp;P MidCap 400 index change.
S&amp;P Global previously announced that AspenTech will be replaced in the index effective prior to the opening of trading on March 11, 2025.

AZPN

Emerson Extends Expiration Of Its Tender Offer To Acquire Aspen Technology Shares Not Already Owned To 5:00 P.M. Eastern Time On March 11, 2025

Emerson (NYSE:<a class="ticker" href="https://www.benzinga.com/stock/EMR#NYSE">EMR</a>) today announced that it has extended the expiration of its tender offer to acquire all outstanding shares of common stock of Aspen Technology, Inc. (NASDAQ:<a class="ticker" href="https://www.benzinga.com/stock/AZPN#NASDAQ">AZPN</a>) ("AspenTech") not already owned by Emerson to 5:00 p.m. Eastern Time on March 11, 2025. This one business day extension is to accommodate the settlement and tendering of shares of AspenTech common stock that may be sold due to the S&amp;P MidCap 400 index change. S&amp;P Global previously announced that AspenTech will be replaced in the index effective prior to the opening of trading on March 11, 2025.

Government

Regulations

Emerson Extends AspenTech Tender Offer by One Day to Align With S&P Index Change

Guidance

DSGN

Design Therapeutics Expects Cash And Equivalents Of $245.5M As Of December 31, 2024, To Fund Its Planned Operating Expenses Into 2029

Press Releases

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Sibanye Stillwater Limited - SBSW

Legal

Attention Sibanye Stillwater Limited Investors: Company Investigated by the Portnoy Law Firm

SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims  On Behalf of Investors of Sibanye Stillwater Limited - SBSW

Mining Stock Rips On Q3 Adjusted EBITDA Results

Commodities

Opinion

Key Metals Surge, Unlocking New Opportunities for Savvy Mining Investors

C5 Capital Signs MOU with Sibanye-Stillwater to Advance Nuclear Energy in South Africa, the United States and Globally

GDXJ

PALL

TSX:PTM

Alpha Metallurgical Resources, Inc. Common Stock

Alpha Metallurgical

Compania De Minas

Coeur Mining

Century Aluminum

Cleveland-Cliffs

Commercial Metals

DRDGOLD Limited American Depositary Shares

DRDGold

Gerdau

Ferroglobe

Warrior Met Coal

Hecla Mining

Harmony Gold Mining Co

Ivanhoe Electric

Kaiser Aluminum Corporation - Common Stock

Kaiser Aluminum

MP Materials

MAC Copper

Materion

Ryerson Holding

Companhia Siderurgica Nacional S.A. Common Stock

Companhia Siderurgica

Grupo Simec, S.A.B. de C.V. American Depositary Shares

Grupo Simec

SunCoke Energy

Ternium S.A. Ternium S.A. American Depositary Shares (each representing ten shares, USD1.00 par value)

Comments

Sibanye Stillwater

Sibanye Stillwater (SBSW) 옵션

Sibanye Stillwater (NYSE:SBSW) 주식, 옵션 체인

뉴스

파트너 / 기고자

벤징가 글로벌